Abstract:
PROBLEM TO BE SOLVED: To provide a diagnostic tool for identification of anti-HCMV antibodies in human serum. SOLUTION: The diagnostic tool comprises a solid support with two sections, wherein the section 1 bears a plurality of HCMV proteins (vp) obtained from purified virions concentrated in separate bands forming a predetermined pattern, one of these bands is pp150 of HCMV; the section 2 bears recombinant fusion proteins as controls, and at least one band comprises a recombinant fusion protein carrying at least one epitope of pp150. COPYRIGHT: (C)2010,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a method useful for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining predisposition to diseases or conditions of the breast such as breast cancer. SOLUTION: A set of contiguous or partially overlapping RNA sequences, and polypeptides encoded thereby, designated as BS106 and transcribed from breast tissue is provided. The sequences are useful for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases or conditions of the breast such as the breast cancer. Furthermore, there is provided an antibody which specifically binds to BS106-encoded polypeptide or protein, and an agonist or inhibitor which prevents action of the tissue-specific BS106 polypeptide, which molecules are useful for the therapeutic treatment of breast diseases, tumors or metastases. COPYRIGHT: (C)2010,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To allow the suturing of vascular puncture sites located at the distal end of a percutaneous tissue tract in devices, systems, and methods for suturing of body lumens. SOLUTION: An elongated articulated foot near a distal end of a shaft is inserted through the penetration and actuated so that the foot extends along the lumenal axis. The foot carries suturing attachment cuffs, and needles are advanced from the shaft through the vessel wall outside of the penetration and into engagement with the needle cuffs after the foot has been drawn proximally up against the endothelial surface of the blood vessel. The cross-section of the shaft within the tissue tract can be minimized by laterally deflecting the needles before they leave the shaft, while tapered depressions within the foot can guide the advancing needles into engagement with the cuffs. COPYRIGHT: (C)2010,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a new macromolecular conjugate useful for diagnostic assays and therapeutic agents. SOLUTION: The conjugate which is a composition comprising a population of conjugates, wherein each conjugate of the population includes a predetermined number of antibodies and the number of antibodies is between 2 and 30, includes three layers of macromolecules, wherein at least two of the three layers includes two or more macromolecules, and wherein the layers form a surface in three dimensions. The conjugate including a specific binding member, two or more end-point molecules, and two or more spacer molecules which substantially separate the end-point molecules. The method of producing a suspended or soluble macromolecular conjugate including binding of a first macromolecule to a solid via a stable, disruptable bond, stably linking of an additional macromolecule, and releasing of a macromolecular conjugate, and the macromolecular conjugate produced by the method. COPYRIGHT: (C)2010,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a compound controlling synapse transmission in a neuron nicotinic cholinergic channel receptor, an intermediate for the synthesis of the compound, and a method for preparing a compound represented by formula (I) using the intermediate. SOLUTION: This compound is 5-(5,5-dimethyl-1,3-hexadienyl)-6-chloro-3-(2-(R)-pyrrolidinylmethoxy)pyridine or its pharmaceutically permissible salt in a 3-pyridyloxymethyl heterocyclic ether compound represented by formula (I). COPYRIGHT: (C)2010,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a compound useful for the treatment of angiogenic diseases of mammals, especially safe in therapeutic use, and usable as an antiangiogenic agent exhibiting selective toxicity to pathological symptoms e.g. by the selective inhibition of the proliferation of endothelial cells without or scarcely developing toxicity to normal (non-cancer) cells. SOLUTION: Mammalian kringle 5 fragments and kringle 5 fusion proteins are disclosed as compounds for treating angiogenic diseases. Methods and compounds for inhibiting angiogenic diseases are also disclosed. The kringle fragment is expressed by structure formula A-B-C-X-Y (in the formula, A is absent or a nitrogen-protective group; Y is absent or a carboxylic acid protective group; B is a natural amino acid residue; C is expressed by formula R 1 -R 2 -R 3 -R 4 (the groups are lysyl, leucyl or arginyl, tyrosyl, etc., and aspartyl, respectively); and X is absent or a natural amino acid residue or the like). COPYRIGHT: (C)2009,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide semisynthetic analogs of rapamycin as a therapeutic agent of immunomodulatory disorders. SOLUTION: Compounds such as semisynthetic analogs of rapamycin and pharmaceutically permissible salts, esters, amides, prodrugs and the like thereof are produced as a starting compound, which rapamycin is one of macrolide compounds obtained by fermentation and is a macrocyclic trien compound produced by Streptomyces hygroscopicus. Production of the intermediate useful for the methods, and use of the pharmaceutical compositions of the active ingredients and for treating immunomodulatory disorders, are provided. COPYRIGHT: (C)2008,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To compensate an influence of a bulk tissue characteristic to noninvasive measurement of an analysis object concentration in an object tissue, relative to an ultrasonic pulse generated in the object tissue in a specimen and propagated. SOLUTION: This analysis method has a step a for irradiating a specimen portion with a near infrared laser pulse from laser sources 15-18, and generating the ultrasonic pulse in the object tissue; a step b for detecting the ultrasonic pulse by a detector 32, and generating the first signal; a step c for generating the ultrasonic pulse in the object tissue by using a laser pulse having the same wavelength and energy as in the step b during an arrangement period of a light absorbing material between the laser sources and the specimen portion so that the ultrasonic pulse is generated in the light absorbing material, propagated through the tissue, and detected by the detector; a step d for detecting the ultrasonic pulse generated in the light absorbing material, and generating the second signal; a step e for calculating the intensity ratio between the first and second signals relative to each wavelength; a step f for calculating an absorption coefficient of the analysis object from the intensity ratio and an optical characteristic of the light absorbing material; and a step g for calculating the concentration of the analysis object from the calculated absorption coefficient, and calculating a molar absorption coefficient of the analysis object. COPYRIGHT: (C)2008,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To improve the accuracy in calibration for the seasonal and physiological variation of tissue characteristics. SOLUTION: The non-invasive measuring device comprises a measuring probe 1, a light source 6, a photodetector, and a computer part 5 which controls the light source and photodetector to measure the information on the glucose in a subject and which estimates the glucose value based on a calibration model output from the photodetector. The computer part 5 determines the calibrated regression parameter of the calibration model, determines the estimated regression parameter of the calibration model by executing the regression operation for a reference measurement value based on the calibration model from an estimated data set, checks the accuracy in the non-invasive measurement from the difference between the glucose concentration estimated using the calibration model based on the result of the non-invasive measurement and the reference glucose concentration, and updates the calibration model. COPYRIGHT: (C)2008,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To pursue temperature-induced glycolysis in the noninvasive measurement of glucose. SOLUTION: The change of glucose metabolism inside a skin nutrition capillary tube is induced, the change of localized reflectance optical signals in a plurality of distances between a light source and a detector and a plurality of wavelengths is measured as the function of the time of bringing a probe into contact with the skin, a time window capable of minimizing the influence of tissue and probe adaptation on signals is selected, and also the signals measured within the time window are used for the following calculation. One set of functions is calculated from a plurality of localized reflectance values in the plurality of distances between the light source and the detector and the plurality of wavelengths at a plurality of time intervals in at least two wavelengths within the time window, calibration relation between the combination of calculation functions and the glucose concentration of a living body is derived, and the calibration relation is used in order to predict the glucose concentration in body liquid in the following measurement. COPYRIGHT: (C)2007,JPO&INPIT